Braingaze

Braingaze brings brain-related healthcare into the digital, AI-empowered era, as well as a convenient and trustworthy patient journey inspired by practice. Braingaze's solutions are the result of over five years of R&D based on scientific tools. These solutions were developed and validated in collaboration with leading clinicians. We focus on the pre-symptomatic stage of Alzheimer's disease and the most common childhood cognitive disorder, ADHD. Our tools have been marketed and received the CE mark as medical devices. Our product portfolio includes detection/diagnostic tools as well as digital therapeutic solutions, which have demonstrated a reduction in symptoms by more than 50%.